Evaluation of semi-homogeneous assay formats for dual-specificity antibodies

Journal of Immunological Methods

Volumn 387, Issue 1-2, 2013, Pages 51-56

  Jiang, Guoying ^a   Lee, Chung W ^a   Wong, Pin Yee ^a   Gazzano Santoro, Hélène ^a  

^a GENENTECH INC   (United States)

Author keywords

Bi specific; Binding; DAF; Semi homogenous

Indexed keywords

ANTIGEN; BISPECIFIC ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BIOTINYLATION; COLORIMETRY; IMMUNOASSAY; IN VITRO STUDY; MICROTITER PLATE ASSAY; PRIORITY JOURNAL; SEMI HOMOGENOUS ASSAY;

ANTIBODIES, BISPECIFIC; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS; IMMUNOASSAY; MODELS, IMMUNOLOGICAL; MODELS, MOLECULAR; PROTEIN BINDING; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS;

EID: 84871414083     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.09.010     Document Type: Article

References (9)

1. Baeuerle P.A., Reinhardt C. Bispecific T-cell engaging antibodies for cancer therapy. Cancer Res. 2009, 69:4941-4944.
2. Bostrom J., Yu S.F., Kan D., Appleton B.A., Lee C.V., Billeci K., Man W., Peale F., Ross S., Wiesmann C., Fuh G. Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site. Science 2009, 323:1610-1614.
3. Deyev S.M., Lebedenko E.N. Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design. Bioessays 2008, 30:904-918.
4. Herold J. Empowered Antibody Therapies - IBC conference. IDrugs 2010, 13:698-700.
5. Hollander N. Bispecific antibodies for cancer therapy. Immunotherapy 2009, 1:211-222.
6. Hudson P.J., Souriau C. Engineered antibodies. Nat. Med. 2003, 9:129-134.
7. McGiven J.A., Sawyer J., Perrett L.L., Brew S.D., Commander N.J., Fisher A., McLarnon S., Harper K., Stack J.A. A new homogeneous assay for high throughput serological diagnosis of brucellosis in ruminants. J. Immunol. Methods 2008, 337:7-15.
8. Nelson A.L., Dhimolea E., Reichert J.M. Development trends for human monoclonal antibody therapeutics. Nat. Rev. Drug Discov. 2010, 9:767.
9. Xie Z., Guo N., Yu M., Hu M., Shen B. A new format of bispecific antibody: highly efficient heterodimerization, expression and tumor cell lysis. J. Immunol. Methods 2005, 296:95-101.